Metabolic modulator

0 marketed 2 in Phase 3

This page covers all Metabolic modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 3-Ketoacyl CoA thiolase (3-KAT).

Targets

3-Ketoacyl CoA thiolase (3-KAT)

Phase 3 pipeline (2)

Trimetazidine hydrochloride · The First Affiliated Hospital of Zhengzhou University · Cardiovascular
Trimetazidine hydrochloride is a metabolic modulator that improves cardiac efficiency by optimizing energy production in heart cells.
Drug: Dose -SM-88 · Pancreatic Cancer Action Network · Oncology
SM-88 is a metabolic modulator that inhibits cancer cell metabolism by targeting key enzymes involved in glucose and amino acid utilization.